Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Grochow

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Cancer Research|August 1, 1990
Phase I and pharmacokinetic study of brequinar sodium (NSC 368390)D A Noe, E K Rowinsky, H S Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenaseS D Baker, S P Khor, A A Adjei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequences of taxol and cisplatin: a phase I and pharmacologic studyE K Rowinsky, M R Gilbert, W P McGuire, et al.
Transplantation|December 1, 1987
Venoocclusive disease of the liver following bone marrow transplantationR J Jones, K S Lee, W E Beschorner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitorE K Rowinsky, L B Grochow, C B Hendricks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracilS D Baker, R B Diasio, S O'Reilly, et al.
Journal of the National Cancer Institute|June 19, 1996
Phase I and pharmacologic studies of topotecan in patients with impaired hepatic functionS O'Reilly, E Rowinsky, W Slichenmyer, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumorsE I Heath, S O'Reilly, R Humphrey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependenceE K Rowinsky, S H Kaufmann, S D Baker, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 1999
Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levelsR A Abrams, L B Grochow, A Chakravarthy, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Cancer Research|August 1, 1990
Phase I and pharmacokinetic study of brequinar sodium (NSC 368390)D A Noe, E K Rowinsky, H S Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenaseS D Baker, S P Khor, A A Adjei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequences of taxol and cisplatin: a phase I and pharmacologic studyE K Rowinsky, M R Gilbert, W P McGuire, et al.
Transplantation|December 1, 1987
Venoocclusive disease of the liver following bone marrow transplantationR J Jones, K S Lee, W E Beschorner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitorE K Rowinsky, L B Grochow, C B Hendricks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracilS D Baker, R B Diasio, S O'Reilly, et al.
Journal of the National Cancer Institute|June 19, 1996
Phase I and pharmacologic studies of topotecan in patients with impaired hepatic functionS O'Reilly, E Rowinsky, W Slichenmyer, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumorsE I Heath, S O'Reilly, R Humphrey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependenceE K Rowinsky, S H Kaufmann, S D Baker, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 1999
Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levelsR A Abrams, L B Grochow, A Chakravarthy, et al.
Pageof 9